Company intelligence / Profile preview

Body Good Studio

Miami, Florida, United Statesbodygoodstudio.com ↗

Ownership: Private
Employees: ~9
Development stage: Commercial

Overview

Body Good Studio offers telehealth-based, evidence-supported weight loss programs for women using GLP-1 medications (e.g., semaglutide, tirzepatide), supplements, and wellness coaching. Their services are designed for both insurance and self-pay clients, incorporating personalized medical oversight and ongoing support. Clinical result details are not publicly disclosed, but they emphasize customer satisfaction, physician involvement, and positive before/after transformations.[5][6]

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: Small moleculeDevicePeptidesHormone
Industry: Non-Academic Healthcare

Drug pipeline

1 asset

semaglutide

Commercial

Indications: Obesity, Weight management

Beyond the preview

Go deeper on Body Good Studio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Body Good Studio.

Explore the full profile